Cited by 7Antifungal resistance and susceptibilityFungal and yeast genetics researchEssential Oils and Antimicrobial Activity

A preliminary evaluation on the antifungal efficacy of VT-1161 against Persister Candida albicans cells in vulvovaginal candidiasis

Open access
Sinoca, Marica, Maione, Angela, Gambino, Edvige, Imparato, Marianna, Galdiero, Marilena, de Alteriis, Elisabetta, Galdiero, Emilia, Guida, Marco·2024·Biomedicines

Abstract

Persister cells are a small fraction of the microbial population that survive lethal concentrations of antimicrobial agents. Candida albicans causes vaginal candidiasis, including recurrent vulvovaginal candidiasis, and may survive common antifungal treatments. The triazole VT-1161 is an antifungal agent that specifically targets fungal CYP51, as opposed to the human CYP enzyme. This work illustrates a new role of VT-1161 in eradicating the biofilm created from the persister cells of a primary biofilm of a clinical vaginal isolate of C. albicans. Antifungal activity was determined by the minimum inhibitory concentration (MIC), and the primary biofilm was treated with amphotericin B to obtain persister cells that were able to form a new biofilm. Results obtained using the new azole VT-1161 showed that VT-1161 not only eradicated a secondary biofilm formed from the persister-derived biofilm and counteracted the adhesion of C. albicans in vitro to human cells but also ameliorated C. albicans-induced infection in vivo in Galleria mellonella larvae, suggesting that it could be proposed as an alternative therapeutic strategy for the treatment of recurrent candidiasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines12020389

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • VT-1161 eradicated AmB-tolerant persisters in biofilms and prevented adhesion of C. albicans to human cells in vitro.

    “Similarly, a new azole, VT-1161, not only eradicated AmB-tolerant persisters in biofilms, but also prevented the adhesion of C. albicans to human cells in vitro [52].”

    From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [52]

    Results §3.3 reports that VT-1161 reduced a secondary biofilm grown from amphotericin B–tolerant persisters; it does not show eradication of the persister cells themselves. Methods §2.7 and Results §3.4 show removal of Candida cells after they had adhered to human HaCaT cells in vitro, rather than prevention of adhesion. Page numbers were not available in our copy. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sinoca, M., Maione, A., Gambino, E., Imparato, M., Galdiero, M., de Alteriis, E., Galdiero, E., & Guida, M.
Affiliations
  • University of Naples Federico II (IT)
  • University of Campania "Luigi Vanvitelli" (IT)
  • Department of Biology, University of Naples Federico II, Via Cinthia, 80126 Naples, Italy
Corresponding author
Galdiero, Emilia
Venue
Biomedicines
Publisher
MDPI AG
Published
2024-02-07
Volume
12
Issue
2
Pages
389
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4391597794
Cited by
7
References
34
Citations by year
2026: 3 · 2025: 4
FWCI
2.41
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Essential Oils and Antimicrobial Activity
Keywords
Candida albicans, vaginal candidiasis, recurrent candidiasis, persister cells, biofilm eradication, azole antifungals, amphotericin B, Galleria mellonella infection model, antifungal susceptibility

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review